515 related articles for article (PubMed ID: 28367072)
1. Natural Compounds as Modulators of Cell Cycle Arrest: Application for Anticancer Chemotherapies.
Bailon-Moscoso N; Cevallos-Solorzano G; Romero-Benavides JC; Orellana MI
Curr Genomics; 2017 Apr; 18(2):106-131. PubMed ID: 28367072
[TBL] [Abstract][Full Text] [Related]
2. Cancer therapy: targeting cell cycle regulators.
Johansson M; Persson JL
Anticancer Agents Med Chem; 2008 Oct; 8(7):723-31. PubMed ID: 18855574
[TBL] [Abstract][Full Text] [Related]
3. Cyclin-dependent protein serine/threonine kinase inhibitors as anticancer drugs.
Roskoski R
Pharmacol Res; 2019 Jan; 139():471-488. PubMed ID: 30508677
[TBL] [Abstract][Full Text] [Related]
4. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
[TBL] [Abstract][Full Text] [Related]
5. Cyclin-dependent protein kinase inhibitors including palbociclib as anticancer drugs.
Roskoski R
Pharmacol Res; 2016 May; 107():249-275. PubMed ID: 26995305
[TBL] [Abstract][Full Text] [Related]
6. [Cell cycle regulation after exposure to ionizing radiation].
Teyssier F; Bay JO; Dionet C; Verrelle P
Bull Cancer; 1999 Apr; 86(4):345-57. PubMed ID: 10341340
[TBL] [Abstract][Full Text] [Related]
7. Cancer and apoptosis: The apoptotic activity of plant and marine natural products and their potential as targeted cancer therapeutics.
Chaudhry GE; Md Akim A; Sung YY; Sifzizul TMT
Front Pharmacol; 2022; 13():842376. PubMed ID: 36034846
[TBL] [Abstract][Full Text] [Related]
8. Current concepts in neuro-oncology: the cell cycle--a review.
Dirks PB; Rutka JT
Neurosurgery; 1997 May; 40(5):1000-13; discussion 1013-5. PubMed ID: 9149259
[TBL] [Abstract][Full Text] [Related]
9. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
[TBL] [Abstract][Full Text] [Related]
10. Cyclins and cell cycle checkpoints.
Johnson DG; Walker CL
Annu Rev Pharmacol Toxicol; 1999; 39():295-312. PubMed ID: 10331086
[TBL] [Abstract][Full Text] [Related]
11. Natural Compounds As Modulators of Non-apoptotic Cell Death in Cancer Cells.
Guamán-Ortiz LM; Orellana MI; Ratovitski EA
Curr Genomics; 2017 Apr; 18(2):132-155. PubMed ID: 28367073
[TBL] [Abstract][Full Text] [Related]
12. Cell cycle molecular targets in novel anticancer drug discovery.
Buolamwini JK
Curr Pharm Des; 2000 Mar; 6(4):379-92. PubMed ID: 10788588
[TBL] [Abstract][Full Text] [Related]
13. Natural flavonoids targeting deregulated cell cycle progression in cancer cells.
Singh RP; Agarwal R
Curr Drug Targets; 2006 Mar; 7(3):345-54. PubMed ID: 16515531
[TBL] [Abstract][Full Text] [Related]
14. Honokiol: A Review of Its Anticancer Potential and Mechanisms.
Ong CP; Lee WL; Tang YQ; Yap WH
Cancers (Basel); 2019 Dec; 12(1):. PubMed ID: 31877856
[TBL] [Abstract][Full Text] [Related]
15. Cyclin/Cdk complexes: their involvement in cell cycle progression and mitotic division.
John PC; Mews M; Moore R
Protoplasma; 2001; 216(3-4):119-42. PubMed ID: 11732181
[TBL] [Abstract][Full Text] [Related]
16. Cell cycle regulation in the G1 phase: a promising target for the development of new chemotherapeutic anticancer agents.
Owa T; Yoshino H; Yoshimatsu K; Nagasu T
Curr Med Chem; 2001 Oct; 8(12):1487-503. PubMed ID: 11562278
[TBL] [Abstract][Full Text] [Related]
17. The role of controlled proteolysis in cell-cycle regulation.
Udvardy A
Eur J Biochem; 1996 Sep; 240(2):307-13. PubMed ID: 8841392
[TBL] [Abstract][Full Text] [Related]
18. Targeting nuclear kinases in cancer: development of cell cycle kinase inhibitors.
Pitts TM; Davis SL; Eckhardt SG; Bradshaw-Pierce EL
Pharmacol Ther; 2014 May; 142(2):258-69. PubMed ID: 24362082
[TBL] [Abstract][Full Text] [Related]
19. Cyclin kinase inhibitors are increased during experimental membranous nephropathy: potential role in limiting glomerular epithelial cell proliferation in vivo.
Shankland SJ; Floege J; Thomas SE; Nangaku M; Hugo C; Pippin J; Henne K; Hockenberry DM; Johnson RJ; Couser WG
Kidney Int; 1997 Aug; 52(2):404-13. PubMed ID: 9263996
[TBL] [Abstract][Full Text] [Related]
20. p53-independent induction of p21 (WAF1/CIP1), reduction of cyclin B1 and G2/M arrest by the isoflavone genistein in human prostate carcinoma cells.
Choi YH; Lee WH; Park KY; Zhang L
Jpn J Cancer Res; 2000 Feb; 91(2):164-73. PubMed ID: 10761703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
